Abraham J. Wu

Radiation Oncology

530 E 74th St
New York, NY 10021

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 201 publications

Maximal Ablative Irradiation Because of Encasement for Patients With Locally Advanced Pancreatic Cancer: A Nonrandomized Clinical Trial.

Maximal Ablative Irradiation Because of Encasement for Patients With Locally Advanced Pancreatic Cancer: A Nonrandomized Clinical Trial.

Journal: JAMA surgery

Published: July 29, 2026

Durvalumab With Radiation Therapy in Patients With Inoperable Locally Advanced Non-Small Cell Lung Cancer Ineligible for Concurrent Chemoradiotherapy (DART).

Durvalumab With Radiation Therapy in Patients With Inoperable Locally Advanced Non-Small Cell Lung Cancer Ineligible for Concurrent Chemoradiotherapy (DART).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 16, 2026

Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848.

Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 15, 2026

Clinical implementation of automated IMRT/VMAT planning for lung cancer radiation therapy using the expedited constrained hierarchical optimization (ECHO) system.

Clinical implementation of automated IMRT/VMAT planning for lung cancer radiation therapy using the expedited constrained hierarchical optimization (ECHO) system.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 08, 2026

A Phase I Study of Cyclical Hypofractionated Palliative Radiotherapy (Quad Shot) for Central Lung Tumors in Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC): Results from the PROMISE 006 Trial Thoracic Quad Shot RT in Stage IV NSCLC.

A Phase I Study of Cyclical Hypofractionated Palliative Radiotherapy (Quad Shot) for Central Lung Tumors in Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC): Results from the PROMISE 006 Trial Thoracic Quad Shot RT in Stage IV NSCLC.

Journal: International journal of radiation oncology, biology, physics

Published: April 01, 2026

NRG-GI007: Phase 1 Study of OBP-301, An Oncolytic Virus, and Definitive Chemoradiation in Locally Advanced Esophageal Cancer.

NRG-GI007: Phase 1 Study of OBP-301, An Oncolytic Virus, and Definitive Chemoradiation in Locally Advanced Esophageal Cancer.

Journal: International journal of radiation oncology, biology, physics

Published: March 30, 2026

Prophylactic Versus Therapeutic Sucralfate in Patients at High Risk for Radiation Esophagitis: Randomized Controlled Trial.

Prophylactic Versus Therapeutic Sucralfate in Patients at High Risk for Radiation Esophagitis: Randomized Controlled Trial.

Journal: Practical radiation oncology

Published: March 09, 2026

Quantifying the risk of sexual dysfunction in men treated with pelvic radiation therapy for locally advanced rectal cancer.

Quantifying the risk of sexual dysfunction in men treated with pelvic radiation therapy for locally advanced rectal cancer.

Journal: Frontiers in oncology

Published: February 18, 2026

Transformer-based cardiac substructure segmentation from contrast and non-contrast computed tomography for radiotherapy planning.

Transformer-based cardiac substructure segmentation from contrast and non-contrast computed tomography for radiotherapy planning.

Journal: Physics and imaging in radiation oncology

Published: November 26, 2025

Safety profile of KRAS G12C inhibitors combined with thoracic radiation therapy.

Safety profile of KRAS G12C inhibitors combined with thoracic radiation therapy.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: November 24, 2025

Safety profile of KRAS G12C inhibitors combined with thoracic radiation therapy.

Safety profile of KRAS G12C inhibitors combined with thoracic radiation therapy.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: November 24, 2025

Late toxicity after peposertib-enhanced chemoradiation in rectal cancer patients managed with organ preservation.

Late toxicity after peposertib-enhanced chemoradiation in rectal cancer patients managed with organ preservation.

Journal: Clinical and translational radiation oncology

Published: November 05, 2025

Showing 1-12 of 201

Last Updated: 09/26/2026